000002933 001__ 2933
000002933 005__ 20251104084313.0
000002933 0247_ $$2DOI$$a10.6083/M4CC0ZGW
000002933 037__ $$aETD
000002933 245__ $$aInfluenza vaccination in children with asthma: a retrospective chart review
000002933 260__ $$bOregon Health and Science University
000002933 269__ $$a2015
000002933 336__ $$aFinal project
000002933 502__ $$bD.N.P.
000002933 520__ $$aAsthma exacerbation during influenza infection may result in pneumonia, hospitalization, and death. The ACIP (Advisory Commission of Immunization Policy)  now recommends cautious use of LAIV (live attenuated influenza vaccine) for children over 5 years, with a diagnosis of asthma, and remains a contraindication for children ages 2-4 years who have had asthma symptoms or wheeze within the last 12 months.  It is critical to determine if the rate of influenza vaccination has changed since the implementation of these new guidelines.
000002933 540__ $$fCC BY
000002933 542__ $$fIn copyright - single owner
000002933 650__ $$aVaccination$$027691
000002933 650__ $$aAsthma$$015168
000002933 650__ $$aChild$$016462
000002933 650__ $$aHospitalization$$020335
000002933 650__ $$aImmunization$$020673
000002933 650__ $$aInfluenza Vaccines$$020803
000002933 650__ $$aRetrospective Studies$$025415
000002933 650__ $$aInfluenza, Human$$020802
000002933 650__ $$aChild, Preschool$$016489
000002933 6531_ $$aretrospective chart review
000002933 691__ $$aSchool of Nursing$$041370
000002933 7001_ $$aStalhandske, Kira$$uOregon Health and Science University$$041354
000002933 8564_ $$94253086f-0357-445c-ac4d-fc4fa75e83e1$$s547002$$uhttps://digitalcollections.ohsu.edu/record/2933/files/3703_etd.pdf$$ePublic$$2fb072c2356478516f20297a218df483d$$31
000002933 905__ $$a/rest/prod/nz/80/5z/94/nz805z94b
000002933 909CO $$ooai:digitalcollections.ohsu.edu:2933$$pstudent-work
000002933 980__ $$aTheses and Dissertations